The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?

C Patel, JML Brotherton, A Pillsbury… - …, 2018 - eurosurveillance.org
Background: A National human papilloma virus (HPV) Vaccination Programme for the
prevention of HPV infection and associated disease using the quadrivalent HPV vaccine …

Recent advances and future directions in clinical management of head and neck squamous cell carcinoma

J Muzaffar, S Bari, K Kirtane, CH Chung - Cancers, 2021 - mdpi.com
Simple Summary Even with recent advances, there are urgent needs for novel therapies to
improve overall survival and decrease toxicities in the management of head and neck …

The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012

KD Shield, J Ferlay, A Jemal… - CA: a cancer journal …, 2017 - Wiley Online Library
By using data from the International Agency for Research on Cancer publication Cancer
Incidence in 5 Continents and GLOBOCAN, this report provides the first consolidated global …

Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica

R Herrero, W Quint, A Hildesheim, P Gonzalez… - PloS one, 2013 - journals.plos.org
Background Human papillomavirus (HPV) infection, particularly with type 16, causes a
growing fraction of oropharyngeal cancers, whose incidence is increasing, mainly in …

Prevalence of human papillomavirus in oropharyngeal cancer: a systematic review

AP Stein, S Saha, JL Kraninger, AD Swick… - The Cancer …, 2015 - journals.lww.com
Purpose The global incidence of oropharyngeal squamous cell carcinoma (OPSCC) has
been increasing, and it has been proposed that a rising rate of human papillomavirus (HPV) …

Global incidence trends in head and neck cancer for HPV-related and-unrelated subsites: A systematic review of population-based studies

F dos Santos Menezes, GA Fernandes, JLF Antunes… - Oral oncology, 2021 - Elsevier
In head and neck cancer (HNC), some subsites are associated with human papillomavirus
(HPV) infection, whereas others are unrelated. Although studies have demonstrated the …

Epidemiology of cancer from the oral cavity and oropharynx

R Lambert, C Sauvaget… - European journal of …, 2011 - journals.lww.com
The classification of sites in tumors of the oral cavity, oropharynx, pharynx, and hypopharynx
varies in the literature. More than 90% of these tumors of the mucosal lining are classified as …

Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis

ML Gillison, L Alemany, PJF Snijders, A Chaturvedi… - Vaccine, 2012 - Elsevier
Human papillomavirus (HPV) infection is causally associated with benign and malignant
diseases of the upper airway, including respiratory papillomatosis and oropharyngeal …

HPV-associated head and neck cancer

EE Vokes, N Agrawal, TY Seiwert - Journal of the National …, 2015 - academic.oup.com
Over the last two decades, it has been recognized that head and neck cancers, primarily in
the oropharynx, can be a distinct entity that is causally related to human papilloma virus …

Epidemiology and clinical aspects of HPV in head and neck cancers

AK Chaturvedi - Head and neck pathology, 2012 - Springer
Human papillomavirus (HPV) infection is now established as a major etiologic factor for
oropharyngeal cancers. Case–control studies conducted around the world show strong and …